Selected article for: "chain reaction and gene sequencing"

Author: Marty, Francisco M; Chemaly, Roy F; Mullane, Kathleen M; Lee, Dong-Gun; Hirsch, Hans H; Small, Catherine B; Bergeron, Anne; Shoham, Shmuel; Ljungman, Per; Waghmare, Alpana; Blanchard, Elodie; Kim, Yae-Jean; McKevitt, Matt; Porter, Danielle P; Jordan, Robert; Guo, Ying; German, Polina; Boeckh, Michael; Watkins, Timothy R; Chien, Jason W; Dadwal, Sanjeet S
Title: A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract
  • Document date: 2019_12_3
  • ID: sl45z4i0_11
    Snippet: For virology assessments, bilateral intranasal samples were obtained using midturbinate adult flocked swabs (Copan Diagnostics, Murrieta, CA, USA) at each study visit [19, 20] . Samples were analyzed using reverse transcription quantitative polymerase chain reaction (RT-qPCR) to determine RSV viral load, RSV sequencing of the F gene to evaluate development of resistance, and a multiplex assay to identify coinfections. All nasal samples were analy.....
    Document: For virology assessments, bilateral intranasal samples were obtained using midturbinate adult flocked swabs (Copan Diagnostics, Murrieta, CA, USA) at each study visit [19, 20] . Samples were analyzed using reverse transcription quantitative polymerase chain reaction (RT-qPCR) to determine RSV viral load, RSV sequencing of the F gene to evaluate development of resistance, and a multiplex assay to identify coinfections. All nasal samples were analyzed at central laboratories; further details are provided in Supplemental methods. Antibody titer and pharmacokinetic methods are described in Supplemental methods.

    Search related documents:
    Co phrase search for related documents
    • antibody titer and chain reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • antibody titer and multiplex assay: 1, 2, 3
    • antibody titer and nasal sample: 1
    • antibody titer and quantitative polymerase: 1, 2
    • central laboratory and chain reaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • central laboratory and multiplex assay: 1, 2
    • chain reaction and coinfection identify: 1, 2
    • chain reaction and multiplex assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and nasal sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • chain reaction and quantitative polymerase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chain reaction and resistance development: 1, 2, 3
    • coinfection identify and multiplex assay: 1
    • intranasal sample and nasal sample: 1
    • multiplex assay and nasal sample: 1
    • multiplex assay and quantitative polymerase: 1, 2, 3, 4
    • multiplex assay and resistance development: 1
    • nasal sample and quantitative polymerase: 1, 2, 3, 4, 5